KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $49.1 billion.

  • Abbott Laboratories' Retained Earnings rose 2572.46% to $49.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $49.1 billion, marking a year-over-year increase of 2572.46%. This contributed to the annual value of $47.3 billion for FY2024, which is 2584.81% up from last year.
  • Per Abbott Laboratories' latest filing, its Retained Earnings stood at $49.1 billion for Q3 2025, which was up 2572.46% from $48.5 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Retained Earnings ranged from a high of $49.1 billion in Q3 2025 and a low of -$8.4 billion during Q4 2021
  • Its 5-year average for Retained Earnings is $33.1 billion, with a median of $36.4 billion in 2023.
  • Its Retained Earnings has fluctuated over the past 5 years, first soared by 385.72% in 2022, then surged by 56645.14% in 2023.
  • Over the past 5 years, Abbott Laboratories' Retained Earnings (Quarter) stood at -$8.4 billion in 2021, then rose by 3.86% to -$8.1 billion in 2022, then surged by 566.45% to $37.6 billion in 2023, then increased by 25.85% to $47.3 billion in 2024, then increased by 3.9% to $49.1 billion in 2025.
  • Its Retained Earnings stands at $49.1 billion for Q3 2025, versus $48.5 billion for Q2 2025 and $47.7 billion for Q1 2025.